GlassScriptPhysician profile
Emily B Levin
NPI 1437140456
$7,061.34
in general payments reported to CMS, 2019-2025
35 companies · $1,230 in 2025
The $1,230 reported for 2025 was more than what a typical Dermatology provider received nationally (typical 2025 total: $772).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $741 · 2020: $543 · 2021: $810 · 2022: $1,144 · 2023: $1,111 · 2024: $1,482 · 2025: $1,230.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,743 · Education: $79.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,743.20 |
| Education | $79.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,104.52 | 2019-2025 | |
| Genzyme Corporation | $951.97 | 2019-2025 | |
| Sun Pharmaceutical Industries INC. | $565.49 | 2020-2025 | Ilumya |
| Pfizer INC. | $464.62 | 2019-2025 | |
| Novartis Pharmaceuticals Corporation | $443.28 | 2019-2025 | |
| Regeneron Healthcare Solutions, INC. | $432.25 | 2020-2025 | Dupixent |
| Galderma Laboratories, L.P. | $419.07 | 2019-2025 | Nemluvio, Dysport, Aklief |
| Janssen Biotech, INC. | $322.05 | 2021-2024 | Tremfya |
| E.R. Squibb & Sons, L.L.C. | $291.07 | 2022-2025 | Sotyktu |
| Leo Pharma INC. | $210.06 | 2021-2025 | Adbry |
| Amgen INC. | $200.07 | 2020-2023 | Enbrel, Otezla |
| Ucb, INC. | $183.07 | 2019-2025 | Bimzelx, Cimzia |
| Lilly USA, LLC | $164.73 | 2019-2025 | Taltz, Ebglyss, Olumiant |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $158.94 | 2019-2022 | |
| Almirall LLC | $155.12 | 2019-2024 | Klisyri, Seysara |
Show all 35 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merz North America, INC. | $125.00 | 2019 | |
| Biofrontera INC. | $95.64 | 2020-2025 | Xepi, Bf-Rhodoled, Ameluz |
| Mayne Pharma Commercial LLC | $87.27 | 2019-2021 | |
| Arcutis Biotherapeutics, INC. | $68.39 | 2023-2024 | Zoryve |
| Aclaris Therapeutics, INC. | $68.29 | 2019 | |
| Vyne Pharmaceuticals INC. | $68.09 | 2020-2021 | |
| Incyte Corporation | $63.47 | 2022-2023 | Opzelura |
| Verrica Pharmaceuticals INC. | $62.93 | 2024-2025 | Ycanth |
| Journey Medical Corporation | $57.93 | 2021-2023 | |
| Dermira, INC. | $47.36 | 2019-2020 | |
| Organon LLC | $43.85 | 2024 | |
| Botanix Sb INC | $39.22 | 2025 | Sofdra |
| Dermavant Sciences, INC. | $38.80 | 2023 | Vtama |
| Epi Health, LLC | $29.73 | 2019-2022 | |
| Allergan, INC. | $26.49 | 2021-2022 | |
| Sandoz INC. | $16.64 | 2019 | |
| Genentech USA, INC. | $16.38 | 2022 | |
| Encore Dermatology INC. | $14.75 | 2019 | |
| Sebela Pharmaceuticals INC. | $12.59 | 2020 | |
| Prugen, INC. Pharmaceuticals | $12.21 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Emily Levin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.